It will be interesting to further investigate whether the control of caspase activation by the FAS activation/EPO level balance is disturbed in some types of anemia with ineffective erythropoiesis; this situation might provide new opportunities for treatment by selectively inducing the apoptosis of abnormal erythroid cells. This evidence concerns the gene FAS and anemia.